BioCentury | Jul 21, 2020
Product Development

Two-dose schedule, infection levels may shift timelines for AZ-Oxford vaccine

...all-time high. Share prices of other biotechs developing COVID-19 vaccines also responded to Monday’s data. Heat Biologics Inc....
BioCentury | May 16, 2020
Product Development

A guide to COVID-19 preclinical vaccine modalities

...APCs to present viral peptides to induce B and T cell immunity. Another method from Heat Biologics Inc....
BioCentury | Mar 28, 2020
Product Development

COVID-19 crisis spurs innovation in rapid diagnostic technologies

...amplification process and fluorescent molecular probes, and is run on the company’s ID NOW hardware. Heat Biologics Inc....
...Cas12 - CRISPR-associated protein 12 Cas13 - CRISPR-associated protein 13 Lauren Martz, Senior Editor Sherlock Biosciences Inc. Mammoth Biosciences Heat Biologics Inc. University...
BioCentury | Mar 28, 2020
Product Development

COVID-19 diagnostic tech tableau

...performs targeted sequence amplification at a constant temperature, and reads out via sequence-specific fluorescent probe. Heat Biologics Inc....
...TCR - T cell receptor Karen Tkach Tuzman, Associate Editor Danaher Corp. Adaptive Biotechnologies Corp. Fluidigm Corp. Sherlock Biosciences Inc. Mammoth Biosciences Heat Biologics Inc. cov19count COVID19 COVID-19 diagnostics cov19count...
BioCentury | Apr 7, 2017
Finance

Taking notice

...NASDAQ:AVEO) 3/28/17 $17.3 $55.2 $65.1 18% Bellicum Pharmaceuticals Inc. (NASDAQ:BLCM) 3/23/17 $69.0 $394.9 $406.1 3% Heat Biologics Inc....
BioCentury | Mar 24, 2017
Financial News

Heat Biologics completes follow-on

...On March 23, immuno-oncology company Heat Biologics Inc. (NASDAQ:HTBX) raised $4 million through the sale of 5 million...
...million shares at $0.80 in a follow-on underwritten by Aegis Capital. Heat Biologics Inc. (NASDAQ:HTBX) Durham, N.C. Alicia Parker Heat Biologics Inc....
BioCentury | Jan 20, 2017
Company News

Heat, Shattuck deal

...to disclose financial terms. Heat Biologics Inc. (NASDAQ:HTBX), Durham, N.C. Shattuck Labs Inc., Austin, Texas Business: Cancer Chris Lieu Heat Biologics Inc. Shattuck...
BioCentury | Jan 6, 2017
Clinical News

HS-410: Additional Ph I/II data

...the combination weekly for 3 weeks at 3, 6 and 12 months after starting therapy. Heat Biologics...
...there was no significant difference between the HS-410 and placebo arms on the primary endpoint. Heat Biologics...
...reported data from the trial (see BioCentury, Feb. 16, 2015 & Feb. 1, 2016 ). Heat Biologics Inc....
BioCentury | Dec 22, 2016
Product R&D

Fever pace for Zika

...School of Medicine in St. Louis ZIKV-117, a patient-derived anti-Zika mAb Preclinical Engineered cell-based platform Heat Biologics Inc....
...Inc. , GlaxoSmithKline plc and Moderna Therapeutics Inc. are developing nucleic acid-based Zika vaccines, while Heat Biologics Inc....
...Zika While other groups are focusing on standard virus-based vaccine platforms and nucleic acid modalities, Heat Biologics Inc....
BioCentury | Nov 8, 2016
Clinical News

Antibody protects fetuses from Zika in preclinical model

...transmission from the mother to the fetus and neutralize infection in the fetus. Last month, Heat Biologics Inc....
Items per page:
1 - 10 of 63
BioCentury | Jul 21, 2020
Product Development

Two-dose schedule, infection levels may shift timelines for AZ-Oxford vaccine

...all-time high. Share prices of other biotechs developing COVID-19 vaccines also responded to Monday’s data. Heat Biologics Inc....
BioCentury | May 16, 2020
Product Development

A guide to COVID-19 preclinical vaccine modalities

...APCs to present viral peptides to induce B and T cell immunity. Another method from Heat Biologics Inc....
BioCentury | Mar 28, 2020
Product Development

COVID-19 crisis spurs innovation in rapid diagnostic technologies

...amplification process and fluorescent molecular probes, and is run on the company’s ID NOW hardware. Heat Biologics Inc....
...Cas12 - CRISPR-associated protein 12 Cas13 - CRISPR-associated protein 13 Lauren Martz, Senior Editor Sherlock Biosciences Inc. Mammoth Biosciences Heat Biologics Inc. University...
BioCentury | Mar 28, 2020
Product Development

COVID-19 diagnostic tech tableau

...performs targeted sequence amplification at a constant temperature, and reads out via sequence-specific fluorescent probe. Heat Biologics Inc....
...TCR - T cell receptor Karen Tkach Tuzman, Associate Editor Danaher Corp. Adaptive Biotechnologies Corp. Fluidigm Corp. Sherlock Biosciences Inc. Mammoth Biosciences Heat Biologics Inc. cov19count COVID19 COVID-19 diagnostics cov19count...
BioCentury | Apr 7, 2017
Finance

Taking notice

...NASDAQ:AVEO) 3/28/17 $17.3 $55.2 $65.1 18% Bellicum Pharmaceuticals Inc. (NASDAQ:BLCM) 3/23/17 $69.0 $394.9 $406.1 3% Heat Biologics Inc....
BioCentury | Mar 24, 2017
Financial News

Heat Biologics completes follow-on

...On March 23, immuno-oncology company Heat Biologics Inc. (NASDAQ:HTBX) raised $4 million through the sale of 5 million...
...million shares at $0.80 in a follow-on underwritten by Aegis Capital. Heat Biologics Inc. (NASDAQ:HTBX) Durham, N.C. Alicia Parker Heat Biologics Inc....
BioCentury | Jan 20, 2017
Company News

Heat, Shattuck deal

...to disclose financial terms. Heat Biologics Inc. (NASDAQ:HTBX), Durham, N.C. Shattuck Labs Inc., Austin, Texas Business: Cancer Chris Lieu Heat Biologics Inc. Shattuck...
BioCentury | Jan 6, 2017
Clinical News

HS-410: Additional Ph I/II data

...the combination weekly for 3 weeks at 3, 6 and 12 months after starting therapy. Heat Biologics...
...there was no significant difference between the HS-410 and placebo arms on the primary endpoint. Heat Biologics...
...reported data from the trial (see BioCentury, Feb. 16, 2015 & Feb. 1, 2016 ). Heat Biologics Inc....
BioCentury | Dec 22, 2016
Product R&D

Fever pace for Zika

...School of Medicine in St. Louis ZIKV-117, a patient-derived anti-Zika mAb Preclinical Engineered cell-based platform Heat Biologics Inc....
...Inc. , GlaxoSmithKline plc and Moderna Therapeutics Inc. are developing nucleic acid-based Zika vaccines, while Heat Biologics Inc....
...Zika While other groups are focusing on standard virus-based vaccine platforms and nucleic acid modalities, Heat Biologics Inc....
BioCentury | Nov 8, 2016
Clinical News

Antibody protects fetuses from Zika in preclinical model

...transmission from the mother to the fetus and neutralize infection in the fetus. Last month, Heat Biologics Inc....
Items per page:
1 - 10 of 63